Aytu BioPharma's EXXUA Antidepressant: Strong Start, Promising Future episode artwork

EPISODE · May 13, 2026 · 2 MIN

Aytu BioPharma's EXXUA Antidepressant: Strong Start, Promising Future

from The Daily News Now! Business

Aytu BioPharmas fiscal Q3 2026 results show promising start for new antidepressant EXXUA, with $2.4M in sales from over 1300 prescriptions by 450+ doctors. Despite net loss of $5.6M, EXXUAs momentum is evident with 51% increase in units shipped from March to April. Positive doctor and patient feedback, along with smooth reimbursements, position EXXUA as a major player in MDD treatment. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8fed7585f326cbc6

NOW PLAYING

Aytu BioPharma's EXXUA Antidepressant: Strong Start, Promising Future

0:00 2:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 2 minutes long.

When was this The Daily News Now! Business episode published?

This episode was published on May 13, 2026.

What is this episode about?

Aytu BioPharmas fiscal Q3 2026 results show promising start for new antidepressant EXXUA, with $2.4M in sales from over 1300 prescriptions by 450+ doctors. Despite net loss of $5.6M, EXXUAs momentum is evident with 51% increase in units shipped...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!